Abstract
In July 2018, a Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli ST131 was isolated from a patient admitted to the Vascular Surgery Unit of the main hospital of Molise region, Central Italy. Sequencing and alignment with the available sequences revealed that the isolate harbored the KPC-2 variant and TEM-1 beta-lactamase. This observation raises great concerns about the spread of carbapenem resistance in national and local settings with high endemicity level of KPC in K. pneumoniae, and underlines the importance of strengthening a proactive surveillance.
Author supplied keywords
Cite
CITATION STYLE
Ripabelli, G., Sammarco, M. L., Scutellà, M., Felice, V., & Tamburro, M. (2020). Carbapenem-Resistant KPC- And TEM-Producing Escherichia coli ST131 Isolated from a Hospitalized Patient with Urinary Tract Infection: First Isolation in Molise Region, Central Italy, July 2018. Microbial Drug Resistance, 26(1), 38–45. https://doi.org/10.1089/mdr.2019.0085
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.